BD HorizonTM BV421 Mouse Anti-Human CD66

Description

Flow cytometric analysis of CD66 expression on human peripheral blood granulocytes. Whole blood was stained with BD Horizon BV421 Mouse Anti-Human CD66 antibody Cat. No. 562741; solid line histogram , or with a BD Horizon BV421 Mouse IgG2a, kappa Isotype Control Cat. No. 562439; dashed line histogram . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes. Flow cytometry was performed using a BD LSR II Flow Cytometer System. Flow cytometric analysis of CD66 expression on human peripheral blood granulocytes. Whole blood was stained with BD Horizon BV421 Mouse Anti-Human CD66 antibody Cat. No. 562741; solid line histogram , or with a BD Horizon BV421 Mouse IgG2a, kappa Isotype Control Cat. No. 562439; dashed line histogram . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes. Flow cytometry was performed using a BD LSR II Flow Cytometer System. Show More Flow cytometric analysis of CD66 expression on human peripheral blood granulocytes. Whole blood was stained with BD Horizon BV421 Mouse Anti-Human CD66 antibody Cat. No. 562741; solid line histogram , or with a BD Horizon BV421 Mouse IgG2a, kappa Isotype Control Cat. No. 562439; dashed line histogram . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes. Flow cytometry was performed using a BD LSR II Flow Cytometer System.